药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Rolitetracycline
Almasilate
Almasilate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rolitetracycline
Magnesium peroxide
Magnesium peroxide can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rolitetracycline
Hydrotalcite
Hydrotalcite can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rolitetracycline
Aluminium acetoacetate
Aluminium acetoacetate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rolitetracycline
Magnesium silicate
Magnesium silicate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rolitetracycline
Bismuth subnitrate
Bismuth subnitrate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rolitetracycline
Lavoltidine
Lavoltidine can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rolitetracycline
Lafutidine
Lafutidine can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rolitetracycline
Magnesium carbonate
Magnesium carbonate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rolitetracycline
Magnesium trisilicate
Magnesium trisilicate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rolitetracycline
Magnesium hydroxide
Magnesium hydroxide can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rolitetracycline
Magaldrate
Magaldrate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rolitetracycline
Roxatidine acetate
Roxatidine acetate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rolitetracycline
Metiamide
Metiamide can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rolitetracycline
Calcium carbonate
Calcium carbonate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rolitetracycline
Aluminum hydroxide
Aluminum hydroxide can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rolitetracycline
Magnesium oxide
Magnesium oxide can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rolitetracycline
Vilazodone
The serum concentration of Vilazodone can be decreased when it is combined with Dabrafenib.
Rolitetracycline
Nebivolol
The serum concentration of Nebivolol can be decreased when it is combined with Dabrafenib.
Rolitetracycline
Cenobamate
The serum concentration of Cenobamate can be decreased when it is combined with Dabrafenib.